BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16174691)

  • 1. Financial anatomy of biomedical research.
    Moses H; Dorsey ER; Matheson DH; Thier SO
    JAMA; 2005 Sep; 294(11):1333-42. PubMed ID: 16174691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flows of financial resources for health research and development in Brazil, 2000-2002.
    Vianna CM; Caetano R; Ortega JA; Façanha LO; Mosegui GB; Siqueira M; Costa TB
    Bull World Health Organ; 2007 Feb; 85(2):124-30. PubMed ID: 17308733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economies of scale and scope in publicly funded biomedical and health research: evidence from the literature.
    Hernandez-Villafuerte K; Sussex J; Robin E; Guthrie S; Wooding S
    Health Res Policy Syst; 2017 Feb; 15(1):3. PubMed ID: 28148292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sponsorship in non-commercial clinical trials: definitions, challenges and the role of Good Clinical Practices guidelines.
    Ravinetto R; De Nys K; Boelaert M; Diro E; Meintjes G; Adoke Y; Tagbor H; Casteels M
    BMC Int Health Hum Rights; 2015 Dec; 15():34. PubMed ID: 26715307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choosing Wisely: Applying Value-Based Economic Principles to Population Science Research Investment.
    Frick KD; Helzlsouer KJ
    Cancer Epidemiol Biomarkers Prev; 2024 Feb; 33(2):179-182. PubMed ID: 38317628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mismatch between the health research and development (R&D) that is needed and the R&D that is undertaken: an overview of the problem, the causes, and solutions.
    Viergever RF
    Glob Health Action; 2013 Oct; 6():22450. PubMed ID: 24119660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Who funds Alzheimer's disease drug development?
    Cummings J; Bauzon J; Lee G
    Alzheimers Dement (N Y); 2021; 7(1):e12185. PubMed ID: 34095442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opportunities and benefits as determinants of the direction of scientific research.
    Bhattacharya J; Packalen M
    J Health Econ; 2011 Jul; 30(4):603-15. PubMed ID: 21683461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redefining cancer research for therapeutic breakthroughs.
    Yuzhalin AE
    Br J Cancer; 2024 Apr; 130(7):1078-1082. PubMed ID: 38424166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Funding of US biomedical research, 2003-2008.
    Dorsey ER; de Roulet J; Thompson JP; Reminick JI; Thai A; White-Stellato Z; Beck CA; George BP; Moses H
    JAMA; 2010 Jan; 303(2):137-43. PubMed ID: 20068207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anatomy of medical research: US and international comparisons.
    Moses H; Matheson DH; Cairns-Smith S; George BP; Palisch C; Dorsey ER
    JAMA; 2015 Jan; 313(2):174-89. PubMed ID: 25585329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Africa non-communicable diseases (NCD) Open Lab: Impact of a portfolio of clinical studies to deepen the understanding of NCDs in sub-Saharan Africa.
    Addo J; Davy M; Newlands A; Orford L; Guta P; Scott R; van Hasselt J; Maher-Edwards G
    J Glob Health; 2024 May; 14():04065. PubMed ID: 38695258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Private health insurance in the United States and Sweden: A comparative review.
    Dave U; Lewis EG; Patel JH; Godbole N
    Health Sci Rep; 2024 Mar; 7(3):e1979. PubMed ID: 38495896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A patent-based analysis of the evolution of basic, mission-oriented, and applied research in European universities.
    Angori G; Marzocchi C; Ramaciotti L; Rizzo U
    J Technol Transf; 2023 Mar; ():1-33. PubMed ID: 37359817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Science, interrupted: Funding delays reduce research activity but having more grants helps.
    Tham WY
    PLoS One; 2023; 18(4):e0280576. PubMed ID: 37099515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental Neurotherapeutics: Surfing the Tidal Wave of New Opportunities.
    Reoma LB; Busza A; Mouradian MM; Kaufmann P; Augustine EF; Frank S; Sutula TP; Cole AJ; Fitter HD; Meurer W; Nath A; Griggs RC
    Ann Neurol; 2023 Mar; 93(3):427-430. PubMed ID: 36546649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of Evidence Supporting United States Guidelines in Pancreatic Adenocarcinoma Treatment.
    Pellat A; Boutron I; Coriat R; Ravaud P
    Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36011054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic literature review to identify ethical, legal, and social responsibilities of nonprofit organizations when funding clinical trials in pediatric cancer.
    Rahimzadeh V; Wolfert S; Buenger V; Campbell C; French R; Ludwinski D; Weinstein A; Barrett C
    Pediatr Blood Cancer; 2022 Sep; 69(9):e29854. PubMed ID: 35713116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep Neural Network-Assisted Drug Recommendation Systems for Identifying Potential Drug-Target Interactions.
    Kalakoti Y; Yadav S; Sundar D
    ACS Omega; 2022 Apr; 7(14):12138-12146. PubMed ID: 35449922
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.